PLA2G4A anticorps (C-Term)
Aperçu rapide pour PLA2G4A anticorps (C-Term) (ABIN470612)
Antigène
Voir toutes PLA2G4A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- Detects endogenous levels of total human cPLA2. Does not cross-react with the secreted PLA2 (sPLA2) or cytosolic Ca2+ independent PLA2 (iPLA2). Species cross-reactivity: Human, mouse and rat.
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Synthetic peptide (KLH coupled) corresponding to the C-terminal residues of human cPLA2.
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: ELISA, IP (1:50), WB (1:1000)
Usage: Suitable for use in ELISA, Western Blot and Immunoprecipitation. Western Blot: 1:1000. Immunoprecipitation: 1:50. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 10 mM HEPES, pH 7.5, 150 mM sodium chloride, 0.1 mg/mL BSA, 50 % glycerol. No preservative added.
-
Agent conservateur
- Without preservative
-
Conseil sur la manipulation
- avoid freeze thaw cycles.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze-thaw cycles.
-
-
- PLA2G4A (Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A))
-
Autre désignation
- cPLA2
-
Pathways
- Inositol Metabolic Process, G-protein mediated Events, VEGF Signaling
Antigène
-